IBDEI0OU ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11605,0)
 ;;=I69.931^^47^534^34
 ;;^UTILITY(U,$J,358.3,11605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11605,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Upper Dominant Side
 ;;^UTILITY(U,$J,358.3,11605,1,4,0)
 ;;=4^I69.931
 ;;^UTILITY(U,$J,358.3,11605,2)
 ;;=^5007558
 ;;^UTILITY(U,$J,358.3,11606,0)
 ;;=I69.933^^47^534^35
 ;;^UTILITY(U,$J,358.3,11606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11606,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Upper Nondominant Side
 ;;^UTILITY(U,$J,358.3,11606,1,4,0)
 ;;=4^I69.933
 ;;^UTILITY(U,$J,358.3,11606,2)
 ;;=^5007559
 ;;^UTILITY(U,$J,358.3,11607,0)
 ;;=I69.998^^47^534^42
 ;;^UTILITY(U,$J,358.3,11607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11607,1,3,0)
 ;;=3^Cerebrovascular Disease,Sequelae,Unspec
 ;;^UTILITY(U,$J,358.3,11607,1,4,0)
 ;;=4^I69.998
 ;;^UTILITY(U,$J,358.3,11607,2)
 ;;=^5007572
 ;;^UTILITY(U,$J,358.3,11608,0)
 ;;=I69.928^^47^534^43
 ;;^UTILITY(U,$J,358.3,11608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11608,1,3,0)
 ;;=3^Cerebrovascular Disease,Speech/Language Deficits,Unspec
 ;;^UTILITY(U,$J,358.3,11608,1,4,0)
 ;;=4^I69.928
 ;;^UTILITY(U,$J,358.3,11608,2)
 ;;=^5007557
 ;;^UTILITY(U,$J,358.3,11609,0)
 ;;=I69.965^^47^534^37
 ;;^UTILITY(U,$J,358.3,11609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11609,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,11609,1,4,0)
 ;;=4^I69.965
 ;;^UTILITY(U,$J,358.3,11609,2)
 ;;=^5007566
 ;;^UTILITY(U,$J,358.3,11610,0)
 ;;=I69.962^^47^534^38
 ;;^UTILITY(U,$J,358.3,11610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11610,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Lt Dominant Side
 ;;^UTILITY(U,$J,358.3,11610,1,4,0)
 ;;=4^I69.962
 ;;^UTILITY(U,$J,358.3,11610,2)
 ;;=^5133588
 ;;^UTILITY(U,$J,358.3,11611,0)
 ;;=I69.964^^47^534^39
 ;;^UTILITY(U,$J,358.3,11611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11611,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Lt Nondominant Side
 ;;^UTILITY(U,$J,358.3,11611,1,4,0)
 ;;=4^I69.964
 ;;^UTILITY(U,$J,358.3,11611,2)
 ;;=^5133589
 ;;^UTILITY(U,$J,358.3,11612,0)
 ;;=I69.961^^47^534^40
 ;;^UTILITY(U,$J,358.3,11612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11612,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Rt Dominant Side
 ;;^UTILITY(U,$J,358.3,11612,1,4,0)
 ;;=4^I69.961
 ;;^UTILITY(U,$J,358.3,11612,2)
 ;;=^5007564
 ;;^UTILITY(U,$J,358.3,11613,0)
 ;;=I69.963^^47^534^41
 ;;^UTILITY(U,$J,358.3,11613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11613,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Rt Nondominant Side
 ;;^UTILITY(U,$J,358.3,11613,1,4,0)
 ;;=4^I69.963
 ;;^UTILITY(U,$J,358.3,11613,2)
 ;;=^5007565
 ;;^UTILITY(U,$J,358.3,11614,0)
 ;;=G90.50^^47^534^44
 ;;^UTILITY(U,$J,358.3,11614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11614,1,3,0)
 ;;=3^Complex Regional Pain Syndrome I,Unspec
 ;;^UTILITY(U,$J,358.3,11614,1,4,0)
 ;;=4^G90.50
 ;;^UTILITY(U,$J,358.3,11614,2)
 ;;=^5004163
 ;;^UTILITY(U,$J,358.3,11615,0)
 ;;=R56.9^^47^534^45
 ;;^UTILITY(U,$J,358.3,11615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11615,1,3,0)
 ;;=3^Convulsions,Unspec
 ;;^UTILITY(U,$J,358.3,11615,1,4,0)
 ;;=4^R56.9
 ;;^UTILITY(U,$J,358.3,11615,2)
 ;;=^5019524
 ;;^UTILITY(U,$J,358.3,11616,0)
 ;;=G37.9^^47^534^46
 ;;^UTILITY(U,$J,358.3,11616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11616,1,3,0)
 ;;=3^Demyelinating Disease of Central Nervous System,Unspec
 ;;^UTILITY(U,$J,358.3,11616,1,4,0)
 ;;=4^G37.9
 ;;^UTILITY(U,$J,358.3,11616,2)
 ;;=^5003828
 ;;^UTILITY(U,$J,358.3,11617,0)
 ;;=G36.9^^47^534^47
